DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Supplies Market to 2027 – Global Analysis and Forecasts by Product & Service; Stage; Drug Type; Application, and Geography” report has been added to ResearchAndMarkets.com’s offering.
The clinical trial supplies market was valued at US$ 1,867.44 million in 2019 and is projected to reach US$ 3,298.91 million by 2027; it is expected to grow at a CAGR of 7.4% from 2020 to 2027.
Increasing pharmaceutical and biopharmaceutical R&D expenditures and increase in several clinical trials are the major factors driving the growth of clinical trial supplies market. However, the rising cost of drug development and the challenges associated with clinical trials mainly due to the negative impact of coronavirus are expected to restrict market growth during the forecast period.
The global clinical trial supplies market is segmented into product & service, stage, drug type, and application. Based on product & service, the clinical trial supplies market is segmented into logistics & distribution, manufacturing, and packaging & labeling. The logistics & distribution segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR in the market during the forecast period. Based on stage, the market is segmented into phase III, phase II, bioequivalence studies, and phase I. The phase III segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.
Based on drug type, the clinical trial supplies market is segmented into small-molecule drugs and biologic drugs. The small-molecule drugs segment held the largest share of the market in 2019; however, biologic drugs segment is estimated to register the highest CAGR in the market during the forecast period. Based on application, the market is segmented into oncology, cardiovascular diseases, neurological disorders, respiratory disorders, and others. The oncology segment holds the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.
Companies Mentioned
- Catalent, Inc.
- Thermo Fisher Scientific, Inc.
- Almac Group
- PCI Pharma Services
- Biocair
- UDG Healthcare plc
- Parexel International Corporation
- Owens & Minor Inc.
- KLIFO
- Rubicon Research Pvt. Ltd.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the clinical trial supplies market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global clinical trial supplies market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Key Topics Covered:
1. Introduction
2. Clinical Trial Supplies Market – Key Takeaways
3. Research Methodology
4. Clinical Trial Supplies – Market Landscape
5. Clinical Trial Supplies – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Pharmaceutical and Biopharmaceutical R&D Expenditures
5.1.2 Increase in Number of Clinical Trials
5.2 Market Restraints
5.2.1 Rising Cost of Drug Development and Clinical Trials
5.2.2 Challenges for Clinical Trials Due to Negative Impact of Coronavirus
5.3 Key Market Opportunities
5.3.1 Growing Opportunities in Developing Nations
5.4 Future Trends
5.4.1 Growing Biosimilars and Biologics Market
5.5 Impact analysis
6. Clinical Trial Supplies Market – Global Analysis
6.1 Global Clinical Trial Supplies Market Revenue Forecast And Analysis
6.2 Global Clinical Trial Supplies Market, By Geography – Forecast And Analysis
6.3 Market Positioning of Key Players
6.3.1 Catalent, Inc.
6.3.2 Thermo Fisher Scientific, Inc.
7. Clinical Trial Supplies Market Analysis – By Product and Service
8. Clinical Trial Supplies Market – By Stage
9. Clinical Trial Supplies Market – By Drug Type
10. Clinical Trial Supplies Market – By Application
11. Clinical Trial Supplies Market – Geographic Analysis
11.1 North America: Clinical Trial Supplies Market
11.2 Europe: Clinical Trial Supplies Market
11.3 Asia Pacific: Clinical Trial Supplies Market
11.4 Middle East & Africa: Clinical Trial Supplies Market
11.5 South and Central America: Clinical Trial Supplies Market
12. Impact Of COVID-19 Pandemic On Global Clinical Trial Supplies Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
13. Clinical Trial Supplies Market – Industry Landscape
14. Clinical Trial Supplies Market – Key Company Profiles
15. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/er3sr
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900